Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Office-sclerotherapy for Epistaxis in HHT
NCT01408732Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Feb 2011
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium tetradecyl sulfate in hereditary hemorrhagic telangiectasia (HHT), sponsored by University of Minnesota. Started Feb 2011; status: completed.
02
Drugs
sodium tetradecyl sulfate
03
Conditions
hereditary hemorrhagic telangiectasia (HHT)
Beyond the preview
Go deeper on NCT01408732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01408732.